A Compounding Problem: How GLP-1s Drove Novo Nordisk’s Rapid Rise and Fall

By /

Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma recover?

Scroll to Top